<div id="readability-page-1"><p>Procter &amp; Gamble Company (The) (NYSE:PG - Get Free Report)'s stock price dropped 1% during mid-day trading on Monday after Wells Fargo &amp; Company lowered their price target on the stock from $170.00 to $158.00. Wells Fargo &amp; Company currently has an overweight rating on the stock. Procter &amp; Gamble traded as low as $139.60 and last traded at $140.3580. Approximately 12,056,750 shares changed hands during mid-day trading, an increase of 15% from the average daily volume of 10,500,720 shares. The stock had previously closed at $141.79.</p><div><p><span></span><span>Get <strong>Procter &amp; Gamble</strong> alerts:</span></p></div><ul><li>Are These 3 Leading Defensive Stocks Too Crowded Heading Into 2026?</li></ul><p>Other analysts have also issued reports about the company. BNP Paribas Exane decreased their price target on Procter &amp; Gamble from $177.00 to $172.00 and set an &#34;outperform&#34; rating on the stock in a research note on Tuesday, September 23rd. JPMorgan Chase &amp; Co. decreased their target price on shares of Procter &amp; Gamble from $165.00 to $157.00 and set a &#34;neutral&#34; rating on the stock in a research report on Thursday, December 18th. Deutsche Bank Aktiengesellschaft lowered their target price on shares of Procter &amp; Gamble from $176.00 to $171.00 and set a &#34;buy&#34; rating for the company in a report on Monday, December 8th. Barclays cut their price target on shares of Procter &amp; Gamble from $153.00 to $151.00 and set an &#34;equal weight&#34; rating on the stock in a research note on Monday, December 8th. Finally, Weiss Ratings  reissued a &#34;hold (c)&#34; rating on shares of Procter &amp; Gamble in a research note on Monday, December 29th. Thirteen equities research analysts have rated the stock with a Buy rating and ten have issued  a Hold rating to the stock. Based on data from MarketBeat, Procter &amp; Gamble presently has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $170.81.</p><p><b>Check Out Our Latest Report on Procter &amp; Gamble</b></p><h2>Insider Transactions at Procter &amp; Gamble</h2><ul><li>3 Smart Defensive Stocks for an Uneasy Market</li></ul><p>In related news, CAO Matthew W. Janzaruk sold 725 shares of the firm's stock in a transaction on Thursday, October 30th. The shares were sold at an average price of $149.57, for a total transaction of $108,438.25. Following the completion of the sale, the chief accounting officer directly owned 979 shares of the company's stock, valued at approximately $146,429.03. This trade represents a 42.55% decrease in their position. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which is accessible through this link. 0.20% of the stock is owned by company insiders. </p><h2>Institutional Trading of Procter &amp; Gamble</h2><p>Several hedge funds and other institutional investors have recently bought and sold shares of PG. Halbert Hargrove Global Advisors LLC bought a new position in  Procter &amp; Gamble in the 3rd quarter worth about $25,000.  Nova Wealth Management Inc. bought a new position in  Procter &amp; Gamble in the 1st quarter worth approximately $26,000.  Signature Resources Capital Management LLC increased its position in  Procter &amp; Gamble by 67.9% in the 2nd quarter. Signature Resources Capital Management LLC now owns 178 shares of the company's stock valued at $28,000 after acquiring an additional 72 shares during the period.  Saranac Partners Ltd bought a new stake in  Procter &amp; Gamble during the 3rd quarter valued at $30,000.  Finally, Corundum Trust Company INC bought a new stake in  Procter &amp; Gamble during the 3rd quarter valued at $32,000. 65.77% of the stock is owned by institutional investors. </p><h2>Procter &amp; Gamble Stock Performance</h2><ul><li>MarketBeat Week in Review – 10/27 - 10/31</li></ul><p>The company has a market cap of $327.98 billion, a P/E ratio of 20.49, a PEG ratio of 4.78 and a beta of 0.39. The company has a quick ratio of 0.51, a current ratio of 0.71 and a debt-to-equity ratio of 0.46. The company has a 50 day moving average price of $145.94 and a 200-day moving average price of $152.12. </p><p>Procter &amp; Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings data on Friday, October 24th. The company reported $1.99 earnings per share for the quarter, beating analysts' consensus estimates of $1.90 by $0.09. The business had revenue of $22.39 billion for the quarter, compared to analysts' expectations of $22.23 billion. Procter &amp; Gamble had a net margin of 19.74% and a return on equity of 32.63%. The company's revenue was up 3.0% on a year-over-year basis. During the same period in the previous year, the business earned $1.93 earnings per share. Procter &amp; Gamble has set its FY 2026 guidance at 6.830-7.100 EPS.  Equities analysts expect that  Procter &amp; Gamble Company will post 6.91 EPS for the current fiscal year. </p><h2>Procter &amp; Gamble Announces Dividend</h2><p>The company also recently declared a quarterly dividend, which was paid on Monday, November 17th. Stockholders of record on Friday, October 24th were given a dividend of $1.0568 per share. The ex-dividend date was Friday, October 24th. This represents a $4.23 annualized dividend and a dividend yield of 3.0%. Procter &amp; Gamble's dividend payout ratio (DPR) is 61.61%. </p><h2>Procter &amp; Gamble Company Profile</h2> (Get Free Report)<p>Procter &amp; Gamble <span>NYSE: PG<span></span></span> is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&amp;G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.  </p><p>P&amp;G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric &amp; Home Care, and Baby, Feminine &amp; Family Care.</p><h2>Featured Stories</h2><ul><li>Five stocks we like better than Procter &amp; Gamble</li><li>Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!</li><li>Do not delete, read immediately</li><li>The $100 Trillion AI Story No One Is Telling You</li><li>This stock gets a 94 out of 100</li><li>3 Overlooked Deductions to Help Potentially Minimize Capital Gains Tax</li></ul><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Procter &amp; Gamble Right Now?</h2><p>Before you consider Procter &amp; Gamble, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter &amp; Gamble wasn't on the list.</p><p>While Procter &amp; Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Procter & Gamble (NYSE:PG) shares fell 1% after Wells Fargo downgraded its price target from $170 to $158, maintaining an overweight rating. The stock traded as low as $139.60, with a last price of $140.36. Other analysts also lowered their targets, with a consensus rating of "Moderate Buy" and a target of $170.81. The company reported $1.99 EPS for the last quarter, exceeding estimates, and has set FY 2026 guidance at 6.830-7.100 EPS. Procter & Gamble has a market cap of $327.98 billion and a P/E ratio of 20.49.</p>

Procter & Gamble (NYSE:PG) Shares Down 1% on Analyst Downgrade